Candida lusitaniae meningitis: Case report and review of the literature

Infectious Diseases in Clinical Practice

Volumn 15, Issue 6, 2007, Pages 359-363

  Crum Cianflone, Nancy F ^a   Butera, Michael ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Pulmonary Medicine and Infectious Disease Medical Group of San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CEFOTAXIME; DEXAMETHASONE; FLUCONAZOLE; FLUCYTOSINE; GENTAMICIN; MEROPENEM; METRONIDAZOLE; VANCOMYCIN;

AGED; ANAMNESIS; BACTERIAL INFECTION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; BRAIN VENTRICULITIS; CANDIDA LUSITANIAE; CASE REPORT; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; RASH; REVIEW;

EID: 36249005366     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/IPC.0b013e3181342f62     Document Type: Review

References (29)

1. Smith LW, Sano ME. Moniliasis with meningeal involvement. J Infect Dis. 1933;53:187-196.
2. Nguyen MH, Yu VL. Meningitis caused by Candida species: an emerging problem in neurosurgical patients. Clin Infect Dis. 1995;21:323-327.
3. Huttova M, Kralinsky K, Horn J, et al. Prospective study of nosocomial fungal meningitis in children - report of 10 cases. Scand J Infect Dis. 1998;30:485-487.
4. Arisoy ES, Arisoy AE, Dunne WM Jr. Clinical significance of fungi isolated form cerebrospinal fluid in children. Pediatr Infect Dis J. 1994;13:128-133.
5. Fernandez M, Moylett EH, Noyola DE, et al. Candidal meningitis in neonates: a 10-year review. Clin Infect Dis. 2000;31:458-463.
6. Fleischmann J, Church JA, Lehrer RI. Case report: Candida meningitis and chronic granulomatous disease. Am J Med Sci. 1986;291:334-341.
7. Marr B, Gross S, Cunningham C, et al. Candidal sepsis and meningitis in a very-low-birth-weight infant successfully treated with fluconazole and flucytosine. Clin Infect Dis. 1994;19:795-796.
8. Casado JL, Quereda C, Oliva J, et al. Candidal meningitis in HIV-infected patients: analysis of 14 cases. Clin Infect Dis. 1997;25:673-676.
9. McCullers JA, Vargas SL, Flynn PM, et al. Candidal meningitis in children with cancer. Clin Infect Dis. 2000;31:451-457.
10. Sanchez-Portocarrero J, Perez-Cecilia E, Corral O, et al. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis. 2000;37:169-179.
11. Bayer AS, Edwards JE, Seidel JS, et al. Candida meningitis. Medicine. 1976;55:477-486.
12. Dorko E, Pilipcinec E, Tkacikova L. Candida species isolated from cerebrospinal fluid. Folia Microbiol (Praha). 2002;47:179-181.
13. Sanchez PJ, Cooper BH. Candida lusitaniae sepsis and meningitis in a neonate. Pediatr Infect Dis J. 1987;6:758-759.
14. Leggiadro RJ, Collins T. Postneurosurgical Candida lusitaniae meningitis. Pediatr Infect Dis J. 1988;7:366-367.
15. Sarma PSA, Durairaj P, Padhye AA. Candida lusitaniae causing fatal meningitis. Postgrad Med J. 1993;69:878-880.
16. Kremery V Jr, Mateicka F, Grausova S, et al. Invasive infections due to Clavispora lusitaniae. FEMS Immunol Med Microbiol. 1999;23:75-78.
17. Pappagianis D, Collins MS, Hector R, et al. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother. 1979;16:123-126.
18. Holzschu DL, Presley HL, Miranda M, et al. Identification of Candida lusitaniae as an opportunistic yeast in humans. J Clin Microbiol. 1979;10:202-205.
19. Voice RA, Bradley SF, Sangeorzan JA, et al. Chronic candidal meningitis: an uncommon manifestation of candidiasis. Clin Infect Dis. 1994;19:60-66.
20. Sanchez-Portocarrero J, Martin-Rabadan P, Daldana CJ, et al. Candida cerebrospinal fluid infection. Report of two new cases and review of the literature. Diagn Microbiol Infect Dis. 1994;20:33-40.
21. Lipton SA, Hickey VF, Morris JH, et al. Candidal infection in the central nervous system. Am J Med. 1984;76:101-109.
22. Geers TA, Gordon SM. Clinical significance of Candida species isolated from cerebrospinal fluid following neurosurgery. Clin Infect Dis. 1999;28:1139-1147.
23. Smego RA, Perfect JR, Durack DT. Combined therapy with amphotericin B and fluorocytosine for Candida meningitis. Rev Infect Dis. 1984;6:791-801.
24. Pappas PG, Rex JH, Sobel JD, et al. Infectious Diseases Society of America. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161-189.
25. Gurses N, Kalyci AG. Fluconazole monotherapy for candidal meningitis in a premature infant. Clin Infect Dis. 1996;23:645-646.
26. Scarcella A, Pasquariello MB, Giugliano B, et al. Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J. 1998;17:146-148.
27. Yoon SA, Vazquez JA, Steffan PE, et al. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob Agents Chemother. 1999;43:836-845.
28. Young LY, Hull CM, Heitman J. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob Agents Chemother. 2003;47:2717-2724.
29. Hawkins JL, Baddour LM. Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis. 2003;36:e14-e18.